Sales Growth YoY (Last Twelve Months): Quince Therapeutics (QNCX)

Graphic logo of Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics (QNCX) relies on innovative management and M&A strategies. Year-over-year sales volatility over a rolling 12-month period illustrates the asset's dynamics, where 0.00 represents the current level of the metric. The absence of recurring revenue makes success dependent on trials, yet a substantial cash reserve ensures coverage of all operating expenses for the development of metabolic drugs.

Sales Growth YoY (Last Twelve Months): quincetx.com (QNCX) for 02/11/2024 - 10/12/2026

Summary analytical data breakdowns for Quince (QNCX)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Fundamental company valuation:QNCX (quincetx.com)
Mass-produced product of Quince Therapeutics Inc

The robotization of drug synthesis at Quince Therapeutics (QNCX) directly impacts the year-over-year revenue growth rate for the TTM period. This indicator measures the dynamics of cash inflows by comparing the current trailing twelve months with the preceding period. The calculation is based on the percentage deviation of total sales over the last four quarters. This allows investors to promptly track the pace of business scaling. The asset is classified as a high-risk technology security.

Who Quince Therapeutics competes with

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)